Xenobiotics Flashcards

1
Q

Compound that is foreign to the body

Compounds in plant food, and synthetic compound in medicines, food additives, and environmental pollutants

A

Xenobiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drugs
Chemical carcinogens
Various compounds

that have found their way into our environment like PCB’s and insecticides

A

Xenobiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Xenobiotics are metabolized or excreted

A

unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Xenobiotics biologic effects:

A

Pharmacologic responses
Toxicity
Immunologic reactions
Cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phase 1 of Xenobiotic Metabolism

Main reaction involved

A

Hydroxylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phase 1 is catalyzed by

A

CYP 450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
Deamination
Dehalogenation
Desulfuration
Epoxidation
Peroxygenation
Reduction
A

Phase 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

To increase water solubility (polarity) and thus excretion from the body

A

Purpose of the 2nd phase of metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Persist in adipose tissue indefinitely

A

Very hydrophobic xenobiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
Conjugation with glucoronic acid
Sulfate
Acetate
Glutathione
Certain amino acids
Methylation
Catalyzes by enzymes such as glucuronosyltransferases, sulfotransfersases, glutathione s-transferases using UDP-glucoronic acid, PAPS (active sulfate) and glutathione respectively as donors
A

Phase 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Xenobiotics are metabolized mainly in the

A

liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Convert the parent drug to a more polar metabolite (active or inactive)

A

Phase 1 reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Endogenous substrate combines with the newly incorporated functional group to form a highly polar conjugate

A

Phase II reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A nonpolar drug absorbed goes into

A

Phase 1

Modified metabolite
Inactive metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hydrophilic drugs goes straight to

A

Excretion or elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A slightly polar drug goes to

A

Phase 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

59/M, Stroke
Aspirin
Clopidogrel
Atorvastatin

Occasional epigastric pain when taking these drugs

Which is discouraged to be given to this patient?

a. Ranitidine
b. Omeprazole
c. Pantoprazole
d. Lansoprazole

A

B

both metabolized by CYP219

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Addition of functional group OH

A

Hydroxylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Enzymes monooxygenase CYP 450 is found in vesicles called

A

Microsomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cytochromes have the metal complex

A

Iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Drug combines with oxidixed FE3+ form of ion in CYP450 becoming a

A

binary complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

NADPH donates electron to the flavoprotein to reduce the oxidized P450 complex by

A

P450 reductase

Fe 3+ becomes Fe 2+ (reduced)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

A second electron from NADPH will serve to reduce oxygen becoming

A

activated oxygen-P450 complex

P450Fe2+O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

P450Fe2+O2 complex transfers oxygen to

A

the drug metabolized forming an oxidized product + H20 from other O atom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
From CYP450 drug is released in
hydroxylated form | addition of OH
26
Drug substrates that undergo aromatic hydroxylations
``` Propranolol Phenobarbital Phenytoin Amphetamine Warfarin 17alpha-ethinyl estradiol Napthalene Phenylbutazone Acetalinide Benzpyrene ```
27
Drug substrates that undergo aliphatic hydroxylations
``` Amobarbital Pentobarbital Secobarbital Chlorpropamide IBUPROFEN meprobamate Glutethimide Phenylbutazone DIGITOXIN ```
28
Drug that undergoes epoxidation
Aldrin
29
Drug substrates that undergo N-Dealkylation | O-Dealkylation
``` Morphine Ethylmorphine Benzphetamine Aminopyrine CAFFEINE THEOPHYLLINE CODEINE p-nitroanisole ```
30
Drug substrates that undergo S-Dealkylation
6-Methylthiopurine | Methitural
31
The only common structural feature of the wide variety of structurally unrelated drugs and chemicals that serve as subtrates in Phase 1 is their
High lipid solubility
32
P450s are remarkably
sluggish catalyst | hence need for second phase reactions
33
Greatest in liver cells and enterocytes
CYP450 Family
34
CYP450 in the liver is found in the
endoplasmic reticulum
35
CYP450 in the adrenal gland is found in the
ER | Mitochondria
36
Main pathway of nicotine metabolism Accounts for 70-80% Coumarin, tobacco nitrosamines Nicotine
Cytochrome 2A6
37
Nicotine is degraded by C2A6 to
Cotinine | 2’ hydroxynicotine
38
Cytochrome that metabolizes ``` Diazepam S-mephenytoin Naproxen Nirvanol Omeprazole Clopidogrel Propranolol ```
CYP2C19
39
Cytochrome that metabolized ``` Warfarin Acetaminophen Caffeine Clomipramine Duloxetene Melatonin Tamoxifen Theophylline ```
CYP1A2
40
Pharmacologic interaction between omeprazole and clopidogrel leads to
Significantly reduced exposure of active metabolite of clopidogrel Reduction in anticlotting activity of Clopidogrel At risk for stroke and MI bec they utilize the same CYP2C19 pathway
41
Metabolizes the following drugs Celecoxib Diclofenac Ibuprofen Losartan
CYP2C9
42
This cytochrome is responsible for over 50% of the prescription drugs metabolized in the liver
Cytochrome 3A4
43
Which of the following will increase the metabolism of Warfarin? a. Grapefruit juice b. Ketoconazole c. Isoniazid d. Rifampin
D
44
Increases the metabolism of drugs on repeated administration Induces P450 by enhancing its synthesis Accelerated substrate mechanism Decreases drug efficacy Dose must be increased
Inducer
45
OCPs have decreased efficacy with concomittant use of
Rifampin Both decreased efficacy
46
Benzopyrene (barbecue) induces
Theophylline
47
Carbamazepine induces
Clonazepam, | Itraconazole
48
Chlorcyclizine induces
Steroid hormones
49
Ethchlorvynol induces
Warfarin
50
Griseofulvin induces
Warfarin
51
Phenytoin induces
``` Cortisol Dexamethasone Digitoxin Itraconazole Theophylline ```
52
Rifampin is induces
``` Coumarin Digitoxin Glucocorticoids Itraconazole Methadone Metoprolol OCP Prednisone Propranolol Quinidine Saquinavir ```
53
Ritonavir is induces
Midazolam
54
St John’s Wort induces
``` Alprazolam Cyclosporin Digoxin Indinavir OCP Ritonavir Simvastatin Tacrolimus Warfarin ```
55
A susbtance that binds to CYP450 and decreases its activity Decreased metabolism of the drug Increased drug efficacy Dose must be decreased
Inhibitor
56
Increases efficacy of valium (diazepam) and may increase its toxic effects inhibitor
Alcohol
57
Allopurinol Chloramphenicol Isoniazid inhibits
Antipyrene Dicumarol Probenecid Tolbutamide
58
Chlorpromazine inhibits
Propranolol
59
Cimetidine inhibits
Chlordiazepoxide Diazepam Warfarin
60
Dicumarol inhibits
Phenytoin
61
Disulfiram inhibits
Antipyrine Ethanol Phenytoin Warfarin
62
Ethanol inhibits
Chlordiazepoxide Diazepam Methanol
63
Grapefruit juice inhibits
``` Alprazolam Atorvastatin Cisapride Cyclosporine Midazolam Triazolam ```
64
Itraconazole inhibits
``` Alfentanil Alprazolam Atorvastatin Cyclosporine Diazepam Digoxin ```
65
OCP inhibit
Antipyrine
66
Ketoconazole inhibits
Astemizole Cyclosporine Terfenadine
67
Spironolactone inhibits
Digoxin
68
Most frequent conjugation reaction of Phase II
Glucoronidation ex. bilirubin
69
Enzyme responsible for glucoronidation Present in the cytosol and ER
Glucoronosyltransferases
70
Acetylation involves the enzyme
N-acetyltransferase in cytosol
71
Acetaminophen undergoes this type of Phase II Conjugation
Glucoronidation ``` Morphine Diazepam N-hydroxydapsone Digitoxin Digoxin ```
72
Isoniazid Sulfonamide Clonazepam Dapsone undergoes this type of Phase II conjugation
acetylation
73
Acetaminophen Ethacrynic acid Bromobenzene undergoes this type of Phase II conjugation
Glutathione conjugation
74
Glutathione conjugation occurs via the enzyme
GSH-S transferase (cytosol, microsome)
75
Acetaminophen undergoes the ff Phase II reactions
Glucurononidation (95%) Glutathione conjugation (5%) Sulfation (95%)
76
Dopamine, epinephrine and histsmine undergoes this Phase II conjugation
Methylation by transmethylase SAM
77
Leukotriene A4 undergoes this type of Phase II conjugation
Water conjugation
78
Therapeutic dose of Acetaminophen in adult
3 g
79
When acetaminophen undergoes glutathione conjugation pathway by CYP2E1 and CYP3A4, GSH is depleted faster than it can be regenated and this metabolite accumulates
N-acetylbenzoiminoquinone
80
If GSH is able to bind to N-acetylbenzoiminoquinone, no toxic metabolite accumulates and this persists instead
Mercapturic acid conjugate
81
N-acetylbenzoiminoquinone binding with Nucleophilic Cell Macromolecule (Protein-SH) leads to Redox recycling, ROS generation, oxidative stress
Liver cell death
82
Antidote for paracetamol toxicity in 8-16 hours
N-acetylcysteine
83
Administration of GSH is not effective in acetaminophen toxicity because
it does not cross cell membranes readily
84
Bacterially mediated reduction of digoxin | De-glucoronidation of bile
Commensal Gut Microbiota
85
Charcoal-broiled foods and cruciferous vegetables: induce CYP1A enzymes Grapefruit juice inhibits CYP3 Cigarette smoke: enzyme induction
Diet and environmental factors
86
Slower metabolism: very young and very old | Young adult male rats metabolize drugs much faster
Age and Sex
87
Digoxin is reduced in the gut by
Bacteria
88
Charbroiled foods and cruciferous vegetables induce
CYP1A
89
Grapefruit inhibits
CYP3A
90
Cigarette is an enzyme
Inducer
91
Bound to active site and ER Induce microsomal enzymes
Lipophilic substrates
92
May enhance also its own metabolism leading to tolerance
Inducer
93
Some drugs require conjugation with endogenous substrates such as GSH, glucuronic acid or sulfate for their inactivation Faster-reacting drug may effectively deplete endogenous substrate levels
Drug-Endogenous Substance Interactions
94
Cirrhosis Hepatitis Biliary cirrhosis
Affect drug metabolism | Impair hepatic enzymes and drug elimination
95
Cardiac disease limits blood flow to liver hence impairs liver metabolism of drugs such as
Lidocaine Isoniazid Morphine
96
Pulmonary diseases affect drug metabolism as indicated by impaired hydrolysis of and increased half life of
Procainamide Procain Antipyrin in lung cancer
97
Endocrine dysfunction on drug metabolism Thyroid dysfunction has been associated with altered metabolism of
Digoxin Methimazole Increased half life
98
Cytokine mediators impair drug metabolism by
inactivating CYP450 | enhancing their degradation
99
Variant allele of a gene at a population frequency of >/= 1% First drugs -> succinylcholine, INH, warfarin Adverse drug reactions -> dose adjustments needed
Genetic polymorphism
100
Genetic variants of enzymes in phase I CYP2C19 Individuals with variant allele for CYP2C19 exhibit increased metabolism of Omeprazole and Clopidogrel Increase dose of the drugs
Phase I Polymorphism
101
Nicotine oxidation is through
CYP2A6 activity
102
If patient has CYP2A6 polymorphism they are
Less prone to lung cancer even if smoker
103
Butyrylcholinesterase deficiency (BCHE) Succinylcholine
Phase II Polymorphism
104
Slow acetylator phenotype NAT2 Common in 50% of blacks Given isoniazid, patient will be prone to developing isoniazid induced periphera neuritis, autoimmune diseases, bladder cancer
Phase II | Polymorphism
105
UGT Polymorphism UGT1A128 Hyperbilirubinemic diseases (Gilbert’s syndrome) Toxic effects due to impaired drug conjugation or elimination such as irinotectan for patients with cancer
Phase II | Polymorphism
106
Phase II Polymorphism
Butyrylcholinesterase Slow acetylator Phenotype NAT2 UGT Polymorphism